Disc Medicine Stock Performance
| IRON Stock | 54.46 0.93 1.74% |
The firm shows a Beta (market volatility) of 0.66, which means possible diversification benefits within a given portfolio. As returns on the market increase, Disc Medicine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Disc Medicine is expected to be smaller as well. At this point, Disc Medicine has a negative expected return of -0.24%. Please make sure to confirm Disc Medicine's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Disc Medicine performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Disc Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 194.8 M |
Disc |
Disc Medicine Relative Risk vs. Return Landscape
If you would invest 6,345 in Disc Medicine on November 28, 2024 and sell it today you would lose (906.00) from holding Disc Medicine or give up 14.28% of portfolio value over 90 days. Disc Medicine is currently does not generate positive expected returns and assumes 2.122% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Disc, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Disc Medicine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Disc Medicine's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Disc Medicine, and traders can use it to determine the average amount a Disc Medicine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IRON |
Estimated Market Risk
| 2.12 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Disc Medicine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Disc Medicine by adding Disc Medicine to a well-diversified portfolio.
Disc Medicine Fundamentals Growth
Disc Stock prices reflect investors' perceptions of the future prospects and financial health of Disc Medicine, and Disc Medicine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Disc Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.18 | ||||
| Current Valuation | 1.39 B | ||||
| Shares Outstanding | 34.29 M | ||||
| Price To Book | 4.01 X | ||||
| EBITDA | (91.03 M) | ||||
| Total Debt | 2.1 M | ||||
| Book Value Per Share | 15.73 X | ||||
| Cash Flow From Operations | (73.46 M) | ||||
| Earnings Per Share | (3.95) X | ||||
| Total Asset | 368 M | ||||
| Retained Earnings | (188.65 M) | ||||
About Disc Medicine Performance
By examining Disc Medicine's fundamental ratios, stakeholders can obtain critical insights into Disc Medicine's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Disc Medicine is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Disc Medicine performance evaluation
Checking the ongoing alerts about Disc Medicine for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Disc Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Disc Medicine generated a negative expected return over the last 90 days | |
| Net Loss for the year was (76.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Disc Medicine generates negative cash flow from operations | |
| Disc Medicine has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors |
- Analyzing Disc Medicine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Disc Medicine's stock is overvalued or undervalued compared to its peers.
- Examining Disc Medicine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Disc Medicine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Disc Medicine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Disc Medicine's stock. These opinions can provide insight into Disc Medicine's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.